GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
antazoline is an approved drug
Compound class:
Synthetic organic
Comment: There is no information regarding approval for clinical use of this drug on the US FDA website. Other national approval agencies may have granted marketing authorisation.
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes. |
IUPAC Name ![]() |
| N-benzyl-N-(4,5-dihydro-1H-imidazol-2-ylmethyl)aniline |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 1142 | antazoline |
Database Links ![]() |
|
| CAS Registry No. | 91-75-8 |
| ChEMBL Ligand | CHEMBL1305 |
| DrugBank Ligand | DB08799 |
| DrugCentral Ligand | 224 |
| GtoPdb PubChem SID | 178103693 |
| PubChem CID | 2200 |
| Search Google for chemical match using the InChIKey | REYFJDPCWQRWAA-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | REYFJDPCWQRWAA |
| Search PubMed clinical trials | antazoline |
| Search PubMed titles | antazoline |
| Search PubMed titles/abstracts | antazoline |
| UniChem Compound Search for chemical match using the InChIKey | REYFJDPCWQRWAA-UHFFFAOYSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | REYFJDPCWQRWAA-UHFFFAOYSA-N |
| Wikipedia | Antazoline |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖|
Antazoline (links to external site)
Cat. No. HY-B1067A |